Unrecognized Citrullinemia Mimicking Encephalitis in a 14-Year-Old Boy: Unexpected Result Through the Use of a Standardized Lumbar Puncture Protocol

Abstract

Citrullinemia is a urea cycle disorder caused by deficiency of argininosuccinate synthetase. Late onset forms can remain undiscovered until a decompensation that can resemble encephalitis. Herein, we report a 14-year old patient with suspected encephalitis with fluctuating episodes of confusion. EEG mainly showed bilateral slowing with some spikes plus spike waves; and was interpreted as suspicious for encephalitis. Brain MRI was normal. Leukocytes in CSF were slightly elevated. Treatment for a CNS infectious disease was begun. Symptoms did not resolve and there were several episodes of confusion, so a repeat lumbar puncture was performed according to a standardized protocol including an amino acid profile. An elevation of citrulline in CSF was found, which ultimately led to the diagnosis of a late onset citrullinemia. The establishment of this diagnosis will protect the patient from the sequelae of unrecognized and thus untreated episodes of hyperammonemia. Thus, following a standardized lumbar puncture protocol can be essential to detect patients with otherwise unrecognized underlying metabolic disorders that are not suspected because of clinical symptoms. In addition, it is important to stress that an ammonia concentration should be determined in any patient with neurological signs like confusion.

Keywords

citrullinemia - encephalitis - ADEM - CSF and plasma amino acids

• References

• 1 Caldovic L, Morizono H, Panglao MG , et al. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles. Hum Mutat 2005; 25 (3) 293-298
• 2 Ficicioglu C, Mandell R, Shih VE. Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening. Mol Genet Metab 2009; 98 (3) 273-277
• 3 Häberle J, Pauli S, Schmidt E, Schulze-Eilfing B, Berning C, Koch HG. Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). Mol Genet Metab 2003; 80 (3) 302-306
• 4 Kurokawa K, Yorifuji T, Kawai M , et al. Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency. J Hum Genet 2007; 52 (4) 349-354
• 5 Mercimek-Mahmutoglu S, Moeslinger D, Häberle J , et al. Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab 2010; 100 (1) 24-28
• 6 Engel K, Höhne W, Häberle J. Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. Hum Mutat 2009; 30 (3) 300-307
• 7 Häberle J, Pauli S, Linnebank M , et al. Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia. Hum Genet 2002; 110 (4) 327-333
• 8 Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis 2007; 30 (5) 631-641
• 9 Sander J, Janzen N, Sander S , et al. Neonatal screening for citrullinaemia. Eur J Pediatr 2003; 162 (6) 417-420
• 10 Dionisi-Vici C, Rizzo C, Burlina AB , et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002; 140 (3) 321-327
• 11 Maestri NE, Brusilow SW, Clissold DB, Bassett SS. Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 1996; 335 (12) 855-859
• 12 Wilcken B, Haas M, Joy P , et al. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics 2009; 124 (2) e241-e248
• 13 Sperl W, Felber S, Skladal D, Wermuth B. Metabolic stroke in carbamyl phosphate synthetase deficiency. Neuropediatrics 1997; 28 (4) 229-234
• 14 Scholl-Bürgi S, Haberlandt E, Heinz-Erian P , et al. Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication. Pediatrics 2008; 121 (4) e920-e926
• 15 Saudubray JM, Desguerre I, Sedel F, Charpentier C. A clinical approach to inherited metabolic diseases. In: Fernandes J, Saudubray JM, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases. 5th ed. Germany: Springer Medizin Verlag; 2006